Ueno T - Search Results

1

Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer.

Ueno T, Toi M, Saji H, Muta M, Bando H, Kuroi K, Koike M, Inadera H, Matsushima K. Ueno T, et al. Clin Cancer Res. 2000 Aug;6(8):3282-9. Clin Cancer Res. 2000. PMID: 10955814

2

Significance of thymidine phosphorylase as a marker of protumor monocytes in breast cancer.

Toi M, Ueno T, Matsumoto H, Saji H, Funata N, Koike M, Tominaga T. Toi M, et al. Among authors: ueno t. Clin Cancer Res. 1999 May;5(5):1131-7. Clin Cancer Res. 1999. PMID: 10353748

3

Significance of membrane type 1 matrix metalloproteinase expression in breast cancer.

Ishigaki S, Toi M, Ueno T, Matsumoto H, Muta M, Koike M, Seiki M. Ishigaki S, et al. Among authors: ueno t. Jpn J Cancer Res. 1999 May;90(5):516-22. doi: 10.1111/j.1349-7006.1999.tb00778.x. Jpn J Cancer Res. 1999. PMID: 10391091 Free PMC article. Clinical Trial.

4

Circulating soluble Fas concentration in breast cancer patients.

Ueno T, Toi M, Tominaga T. Ueno T, et al. Clin Cancer Res. 1999 Nov;5(11):3529-33. Clin Cancer Res. 1999. PMID: 10589768

5

Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration.

Ueno T, Toi M, Koike M, Nakamura S, Tominaga T. Ueno T, et al. Br J Cancer. 2000 Jul;83(2):164-70. doi: 10.1054/bjoc.2000.1272. Br J Cancer. 2000. PMID: 10901365 Free PMC article.

6

[New molecular target of cancer therapy--angiogenesis regulator VEGF].

Toi M, Ueno T, Tominaga T. Toi M, et al. Among authors: ueno t. Gan To Kagaku Ryoho. 1997 Dec;24(15):2202-6. Gan To Kagaku Ryoho. 1997. PMID: 9422062 Review. Japanese.

7

Significance of circulating hepatocyte growth factor level as a prognostic indicator in primary breast cancer.

Toi M, Taniguchi T, Ueno T, Asano M, Funata N, Sekiguchi K, Iwanari H, Tominaga T. Toi M, et al. Among authors: ueno t. Clin Cancer Res. 1998 Mar;4(3):659-64. Clin Cancer Res. 1998. PMID: 9533534

8

Measurement of an apoptotic product in the sera of breast cancer patients.

Ueno T, Toi M, Bivén K, Bando H, Ogawa T, Linder S. Ueno T, et al. Eur J Cancer. 2003 Apr;39(6):769-74. doi: 10.1016/s0959-8049(02)00865-1. Eur J Cancer. 2003. PMID: 12651202

9

Modulation of thymidine phosphorylase by neoadjuvant chemotherapy in primary breast cancer.

Toi M, Bando H, Horiguchi S, Takada M, Kataoka A, Ueno T, Saji S, Muta M, Funata N, Ohno S. Toi M, et al. Among authors: ueno t. Br J Cancer. 2004 Jun 14;90(12):2338-43. doi: 10.1038/sj.bjc.6601845. Br J Cancer. 2004. PMID: 15150550 Free PMC article. Clinical Trial.

10

Increases in circulating VEGF levels during COX-2 inhibitor treatment in breast cancer patients.

Ueno T, Chow LW, Toi M. Ueno T, et al. Biomed Pharmacother. 2006 Jul;60(6):277-9. doi: 10.1016/j.biopha.2006.06.005. Epub 2006 Jun 23. Biomed Pharmacother. 2006. PMID: 16806797 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,551 results

Search Page

Filters